mias pharma uk limited
mias pharma uk limited Company Information
Company Number
14844184
Next Accounts
Sep 2025
Shareholders
mias pharma limited
Group Structure
View All
Industry
Technical testing and analysis
+2Registered Address
vision park chivers way, histon, cambs, CB24 9AD
Website
miaspharma.commias pharma uk limited Estimated Valuation
Pomanda estimates the enterprise value of MIAS PHARMA UK LIMITED at £200.1k based on a Turnover of £293k and 0.68x industry multiple (adjusted for size and gross margin).
mias pharma uk limited Estimated Valuation
Pomanda estimates the enterprise value of MIAS PHARMA UK LIMITED at £0 based on an EBITDA of £-156k and a 3.71x industry multiple (adjusted for size and gross margin).
mias pharma uk limited Estimated Valuation
Pomanda estimates the enterprise value of MIAS PHARMA UK LIMITED at £0 based on Net Assets of £-155.5k and 2.16x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Mias Pharma Uk Limited Overview
Mias Pharma Uk Limited is a live company located in cambs, CB24 9AD with a Companies House number of 14844184. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in May 2023, it's largest shareholder is mias pharma limited with a 100% stake. Mias Pharma Uk Limited is a startup, micro sized company, Pomanda has estimated its turnover at £293k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Mias Pharma Uk Limited Health Check
Pomanda's financial health check has awarded Mias Pharma Uk Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 7 areas for improvement. Company Health Check FAQs
2 Strong
1 Regular
7 Weak
Size
annual sales of £293k, make it smaller than the average company (£4.2m)
- Mias Pharma Uk Limited
£4.2m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Mias Pharma Uk Limited
- - Industry AVG
Production
with a gross margin of 24.5%, this company has a higher cost of product (47.5%)
- Mias Pharma Uk Limited
47.5% - Industry AVG
Profitability
an operating margin of -53.2% make it less profitable than the average company (1.7%)
- Mias Pharma Uk Limited
1.7% - Industry AVG
Employees
with 2 employees, this is below the industry average (39)
2 - Mias Pharma Uk Limited
39 - Industry AVG
Pay Structure
on an average salary of £61.3k, the company has an equivalent pay structure (£61.3k)
- Mias Pharma Uk Limited
£61.3k - Industry AVG
Efficiency
resulting in sales per employee of £146.5k, this is more efficient (£121.8k)
- Mias Pharma Uk Limited
£121.8k - Industry AVG
Debtor Days
it gets paid by customers after 114 days, this is later than average (57 days)
- Mias Pharma Uk Limited
57 days - Industry AVG
Creditor Days
its suppliers are paid after 429 days, this is slower than average (40 days)
- Mias Pharma Uk Limited
40 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Mias Pharma Uk Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 2 weeks, this is less cash available to meet short term requirements (23 weeks)
2 weeks - Mias Pharma Uk Limited
23 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 248.4%, this is a higher level of debt than the average (55.1%)
248.4% - Mias Pharma Uk Limited
55.1% - Industry AVG
MIAS PHARMA UK LIMITED financials
Mias Pharma Uk Limited's latest turnover from December 2023 is estimated at £293 thousand and the company has net assets of -£155.5 thousand. According to their latest financial statements, Mias Pharma Uk Limited has 2 employees and maintains cash reserves of £12.9 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | |
|---|---|
| Turnover | |
| Other Income Or Grants | |
| Cost Of Sales | |
| Gross Profit | |
| Admin Expenses | |
| Operating Profit | |
| Interest Payable | |
| Interest Receivable | |
| Pre-Tax Profit | |
| Tax | |
| Profit After Tax | |
| Dividends Paid | |
| Retained Profit | |
| Employee Costs | |
| Number Of Employees | 2 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | |
|---|---|
| Tangible Assets | |
| Intangible Assets | |
| Investments & Other | |
| Debtors (Due After 1 year) | |
| Total Fixed Assets | |
| Stock & work in progress | |
| Trade Debtors | 91,900 |
| Group Debtors | |
| Misc Debtors | |
| Cash | 12,876 |
| misc current assets | |
| total current assets | 104,776 |
| total assets | 104,776 |
| Bank overdraft | |
| Bank loan | |
| Trade Creditors | 260,294 |
| Group/Directors Accounts | |
| other short term finances | |
| hp & lease commitments | |
| other current liabilities | |
| total current liabilities | 260,294 |
| loans | |
| hp & lease commitments | |
| Accruals and Deferred Income | |
| other liabilities | |
| provisions | |
| total long term liabilities | |
| total liabilities | 260,294 |
| net assets | -155,518 |
| total shareholders funds | -155,518 |
| Dec 2023 | |
|---|---|
| Operating Activities | |
| Operating Profit | |
| Depreciation | |
| Amortisation | |
| Tax | |
| Stock | |
| Debtors | 91,900 |
| Creditors | 260,294 |
| Accruals and Deferred Income | |
| Deferred Taxes & Provisions | |
| Cash flow from operations | |
| Investing Activities | |
| capital expenditure | |
| Change in Investments | |
| cash flow from investments | |
| Financing Activities | |
| Bank loans | |
| Group/Directors Accounts | |
| Other Short Term Loans | |
| Long term loans | |
| Hire Purchase and Lease Commitments | |
| other long term liabilities | |
| share issue | |
| interest | |
| cash flow from financing | |
| cash and cash equivalents | |
| cash | 12,876 |
| overdraft | |
| change in cash | 12,876 |
mias pharma uk limited Credit Report and Business Information
Mias Pharma Uk Limited Competitor Analysis
Perform a competitor analysis for mias pharma uk limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other micro companies, companies in CB24 area or any other competitors across 12 key performance metrics.
mias pharma uk limited Ownership
MIAS PHARMA UK LIMITED group structure
Mias Pharma Uk Limited has no subsidiary companies.
Ultimate parent company
MIAS PHARMA UK LIMITED
14844184
mias pharma uk limited directors
Mias Pharma Uk Limited currently has 5 directors. The longest serving directors include Ms Ann McGee (May 2023) and Mr Vincent Bremmer (Jul 2024).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Ann McGee | England | 63 years | May 2023 | - | Director |
| Mr Vincent Bremmer | Netherlands | 50 years | Jul 2024 | - | Director |
| Mr Pierre Baviera | Ireland | 48 years | Jul 2024 | - | Director |
| Mr Milan Portengen | Netherlands | 35 years | Jul 2024 | - | Director |
| Ms Britt Schuurs | England | 36 years | Jul 2024 | - | Director |
P&L
December 2023turnover
293k
0%
operating profit
-156k
0%
gross margin
24.5%
0%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
-155.5k
0%
total assets
104.8k
0%
cash
12.9k
0%
net assets
Total assets minus all liabilities
Similar Companies
mias pharma uk limited company details
company number
14844184
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
71200 - Technical testing and analysis
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
May 2023
age
2
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
December 2023
previous names
N/A
accountant
-
auditor
-
address
vision park chivers way, histon, cambs, CB24 9AD
Bank
-
Legal Advisor
-
mias pharma uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to mias pharma uk limited.
mias pharma uk limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for MIAS PHARMA UK LIMITED. This can take several minutes, an email will notify you when this has completed.
mias pharma uk limited Companies House Filings - See Documents
| date | description | view/download |
|---|
